Skip to main content
. 2021 Feb;23(2):253–263. doi: 10.1016/j.jmoldx.2020.11.003

Figure 6.

Figure 6

TERT promoter hypermethylation status. TERT promoter hypermethylation upstream of the transcriptional start site, including at the cg11625005 CpG site, was evaluated for 57 cases profiled by Memorial Sloan Kettering Cancer Center Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) to assess for mutual exclusivity of hypermethylation with cases harboring promoter mutations and amplification. n = 42 cases harboring promoter mutations; n = 1 case harboring amplification.